Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 4Phase EARLY_PHASE1 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 263Genitourinary 163Breast 155Tumor-Agnostic 135Thoracic 95Dermatologic 68Head & Neck 58CNS 57Sarcoma 51Gynecologic 44Endocrine 29NET 10Lymphoid 6Other hematologic neoplasm 4Myeloid 4Other solid neoplasm 3Classical hematology 3Plasma cell 2Other 1

Conditions

Myelodysplastic Syndromes 522Leukemia, Myeloid, Acute 404Leukemia, Myelogenous, Chronic, BCR-ABL Positive 308Leukemia 292Precursor Cell Lymphoblastic Leukemia-Lymphoma 234Myeloproliferative Disorders 209Lymphoma, Non-Hodgkin 167Leukemia, Myelomonocytic, Chronic 156Leukemia, Lymphocytic, Chronic, B-Cell 147Hodgkin Disease 142Primary Myelofibrosis 141Multiple Myeloma 133Leukemia, Myeloid, Chronic-Phase 133Lymphoma 114Leukemia, Myeloid, Accelerated Phase 96Blast Crisis 94Anemia, Refractory, with Excess of Blasts 89Polycythemia Vera 88Lymphoma, Follicular 84Burkitt Lymphoma 81Lymphoma, Mantle-Cell 80Myelodysplastic-Myeloproliferative Diseases 78Lymphoma, B-Cell, Marginal Zone 77Lymphoma, Large B-Cell, Diffuse 73Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 70Congenital Abnormalities 70Neoplasms, Plasma Cell 59Lymphoma, Large-Cell, Immunoblastic 59Thrombocythemia, Essential 57Graft vs Host Disease 57

Interventions

sargramostim 1ruxolitinib 1fludarabine phosphate 1fludarabine 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclosporine 1Cyclophosphamide 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × Myeloid × Clear all
NCT06987058 2025-09-24

ROVER-01

Ryvu Therapeutics SA

Phase 2 Not yet recruiting
10 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Myeloid, Acute

NCT06397313 2025-09-23

POTAMI-61

Ryvu Therapeutics SA

Phase 2 Recruiting
230 enrolled
Myeloid

Neoplasm Metastasis, Primary Myelofibrosis

NCT00384956 2016-12-12

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

Washington University School of Medicine

Phase 2 Completed
25 enrolled 13 charts
Myeloid

Myelodysplastic Syndromes, Neoplasm Metastasis

NCT00533923 2016-07-18

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Beth Israel Deaconess Medical Center

Phase 2 Completed
25 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡